Pentoxifylline reduces acute lung injury in chronic endotoxemia.

[1]  R. McIntyre,et al.  TNF receptor I mediates chemokine production and neutrophil accumulation in the lung following systemic lipopolysaccharide. , 2001, The Journal of surgical research.

[2]  R. Dickerson,et al.  Effect of pentoxifylline on nitrogen balance and 3-methylhistidine excretion in parenterally fed endotoxemic rats. , 2001, Nutrition.

[3]  T. Scalea,et al.  Acute respiratory distress syndrome among trauma patients: trends in ICU mortality, risk factors, complications and resource utilization , 2001, Intensive Care Medicine.

[4]  J. Hogg,et al.  Interleukin-6 changes deformability of neutrophils and induces their sequestration in the lung. , 2001, American journal of respiratory and critical care medicine.

[5]  H. Hashimoto,et al.  Pentoxifylline induces the shedding of L-selectin on polymorphonuclear cells by stimulation via adenosine receptor as well as by the inhibition of phosphodiesterase , 2001, Modern rheumatology.

[6]  M. Wilson,et al.  Lazaroid and pentoxifylline suppress sepsis-induced increases in renal vascular resistance via altered arachidonic acid metabolism. , 2000, The Journal of surgical research.

[7]  P. Wang,et al.  Mechanism of the beneficial effects of pentoxifylline during sepsis: maintenance of adrenomedullin responsiveness and downregulation of proinflammatory cytokines. , 2000, The Journal of surgical research.

[8]  T. Krakauer.  Pentoxifylline inhibits ICAM-1 expression and chemokine production induced by proinflammatory cytokines in human pulmonary epithelial cells. , 2000, Immunopharmacology.

[9]  B. Beck-Schimmer,et al.  Lipopolysaccharide induces functional ICAM-1 expression in rat alveolar epithelial cells in vitro. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[10]  R. Coimbra,et al.  Hypertonic saline and pentoxifylline prevent lung injury and bacterial translocation after hemorrhagic shock. , 1999, Shock.

[11]  S. Tasaka,et al.  CD11/CD18-dependent and -independent neutrophil emigration in the lungs: how do neutrophils know which route to take? , 2000, American journal of respiratory cell and molecular biology.

[12]  G. Zibari,et al.  Effects of dextran and pentoxifylline on hemorrhagic shock-induced P-selectin expression. , 1999, The Journal of surgical research.

[13]  K. Ley,et al.  P-selectin and ICAM-1 mediate endotoxin-induced neutrophil recruitment and injury to the lung and liver. , 1999, The American journal of physiology.

[14]  R. Shenkar,et al.  Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: roles of reactive oxygen intermediates, NF-kappa B, and cyclic AMP response element binding protein. , 1999, Journal of immunology.

[15]  H. Repo,et al.  Mechanisms and consequences of phagocyte adhesion to endothelium. , 1999, Annals of medicine.

[16]  M. Yen,et al.  Pentoxifylline improves circulatory failure and survival in murine models of endotoxaemia. , 1999, European journal of pharmacology.

[17]  R. Urbaschek,et al.  Pentoxifylline improves bacterial clearance during hemorrhage and endotoxemia. , 1999, Critical care medicine.

[18]  D. Breuillé,et al.  Cytokine modulation by PX differently affects specific acute phase proteins during sepsis in rats. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[19]  C. Wiedermann,et al.  Pentoxifylline Differentially Regulates Migration and Respiratory Burst Activity of the Neutrophil a , 1997, Annals of the New York Academy of Sciences.

[20]  H. Redmond,et al.  INTERCELLULAR ADHESION MOLECULE‐1 (ICAM‐1) IS EXPRESSED ON HUMAN NEUTROPHILS AND IS ESSENTIAL FOR NEUTROPHIL ADHERENCE AND AGGREGATION , 1997, Shock.

[21]  C. Parkos.  I. Neutrophil adhesive interactions with intestinal epithelium. , 1997, American journal of physiology. Gastrointestinal and liver physiology.

[22]  P. Ward,et al.  Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharide. , 1997, American journal of respiratory cell and molecular biology.

[23]  R. McIntyre,et al.  Pentoxifylline treatment attenuates pulmonary vasomotor dysfunction in acute lung injury. , 1997, The Journal of surgical research.

[24]  Y. Mándi,et al.  Effects of tumor necrosis factor and pentoxifylline on ICAM-1 expression on human polymorphonuclear granulocytes. , 1997, International Archives of Allergy and Immunology.

[25]  D. Hoyt,et al.  Acute lung injury in endotoxemic rats is associated with sustained circulating IL-6 levels and intrapulmonary CINC activity and neutrophil recruitment--role of circulating TNF-alpha and IL-beta? , 1996, Shock.

[26]  J. Hakim,et al.  Inhibition of human neutrophil binding to hydrogen peroxide-treated endothelial cells by cAMP and hydroxyl radical scavengers. , 1996, Free radical biology & medicine.

[27]  A. Nüssler,et al.  Proinflammatory cytokines and endotoxin stimulate ICAM-1 gene expression and secretion by normal human hepatocytes. , 1994, Immunology.

[28]  T. van der Poll,et al.  Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees. , 1993, Journal of immunology.

[29]  A. Fowler,et al.  Role of the neutrophil in adult respiratory distress syndrome , 1993, The British journal of surgery.

[30]  V. Nadkarni,et al.  Effects of in vivo pentoxifylline treatment on survival and ex vivo vascular contractility in a rat lipopolysaccharide shock model. , 1992, Circulatory shock.

[31]  E. Chi,et al.  Pulmonary effects of continuous endotoxin infusion in the rat. , 1991, Circulatory shock.

[32]  R. Gerzer,et al.  Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells. , 1991, Immunology.

[33]  R. Strieter,et al.  Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofylline , 1988 .

[34]  W. J. Novick,et al.  Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline , 1988, Infection and immunity.

[35]  R. Vestal,et al.  Polymorphonuclear leukocyte inhibition by therapeutic concentrations of theophylline is mediated by cyclic-3',5'-adenosine monophosphate. , 1988, The American review of respiratory disease.

[36]  J. Michael,et al.  Pharmacological modification of pulmonary vascular injury: possible role of cAMP. , 1987, Journal of applied physiology.

[37]  D. Strandness,et al.  Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. , 1982, American heart journal.